Lloyd Inc Recalls Subpotent Thyro-Tab 0.75 mg Tablets
Lloyd Inc is recalling 1,913,236 Thyro-Tab 0.75 mg tablets because they failed potency testing at the 6-month interval.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II. Per the rubric, FDA Class II recalls are assigned a score of 4 (Severe), particularly when involving significant health risks like subpotent medication, even if specific hospitalization reports are not detailed in the provided text snippet.
Plain-English summary
Lloyd Inc is recalling 1,913,236 tablets of Thyro-Tab 0.75 mg, packaged in bulk drums for repackaging. The product is labeled with the firm name Lloyd Pharmaceutical, Shenandoah, Iowa 51601. The recall is due to the product being subpotent, specifically showing low assay results at the 6-month test interval.
The affected product was distributed nationwide. The specific code for the recalled lot is HD17811.
Consumers should stop using the recalled product and contact their healthcare provider or pharmacist for guidance on obtaining a replacement or alternative treatment. The FDA has classified this recall as Class II, indicating that use of or exposure to the product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Thyro-Tab.075 mg., packaged in bulk drums for repackaging. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, Iowa 51601.
- Manufacturer
- Lloyd Inc
- Category
- Drug — Thyroid Medication
- Hazard
- Affected units
- 1,913,236
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- HD17811
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Lloyd Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Lloyd Inc
See all →- ModerateLloyd Inc Recalls Subpotent Levothroid Levothyroxine Sodium Tablets
FDA (Drugs) · 2012-07-04
- ModerateLloyd Inc Recalls Subpotent Thyro-Tab 0.050mg Bulk Tablets
FDA (Drugs) · 2012-07-04
- ModerateLloyd Inc Recalls Subpotent Levothroid Levothyroxine Sodium Tablets
FDA (Drugs) · 2012-07-04
Same hazard · subpotent drug
See all →- LowImprimisRx Recalls Subpotent Povidone Iodine and Proparacaine Ophthalmic Solution
FDA (Drugs) · 2026-09-16
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets
FDA (Drugs) · 2026-09-02
Similar recalls
- HighLloyd Inc. Recalls Subpotent Thyro-Tab 0.075 mg. Tablets
FDA (Drugs) · 2013-01-02
- SevereLloyd Inc. Recalls Subpotent Thyro-Tab 0.050 mg. Tablets
FDA (Drugs) · 2013-01-02
- ModerateLloyd Inc Recalls Subpotent Thyro-Tab 0.050mg Bulk Tablets
FDA (Drugs) · 2012-07-04
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2012-12-12
- ModerateLloyd Inc. Recalls Thyro-Tab 0.125 mg. Tablets Due to cGMP Deviations
FDA (Drugs) · 2012-12-12
- SevereLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Failures
FDA (Drugs) · 2013-05-29